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Abstract
Background: Dendritic cells capture antigens through PRRs and modulate adaptive immune responses. The type of
adaptive immune T cell response generated is dependent upon the type of PRR activated by the microbes. Dectin-1 is a C-
type lectin receptor present on dendritic cells.
Methodology/Principal Findings: Here we show that selective dectin-1 agonist Curdlan can activate human DCs and
induce the secretion of large amounts of IL-23, IL-1b, IL-6 and low levels of IL-12p70 as determined by ELISA. The Curdlan-
stimulated DCs are efficient at priming naı ¨ve CD4 cells to differentiate into Th17 and Th1 cells. Furthermore, these CD4 T
cells induce differentiation of B cells to secrete IgG and IgA. In addition, Curdlan-stimulated DCs promote the expansion and
differentiation of Granzyme and perforin expressing cytotoxic T lymphocyte that display high cytolytic activity against
target tumor cells in vitro.
Conclusions/Significance: These data demonstrate that DCs stimulated through Dectin-1 can generate efficient Th, CTL and
B cell responses and can therefore be used as effective mucosal and systemic adjuvants in humans.
Citation: Agrawal S, Gupta S, Agrawal A (2010) Human Dendritic Cells Activated via Dectin-1 Are Efficient at Priming Th17, Cytotoxic CD8 T and B Cell
Responses. PLoS ONE 5(10): e13418. doi:10.1371/journal.pone.0013418
Editor: Fu-Sheng Wang, Beijing Institute of Infectious Diseases, China
Received April 15, 2010; Accepted September 18, 2010; Published October 18, 2010
Copyright:  2010 Agrawal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study is supported by a New Scholar grant from the Ellison Medical Foundation (www.ellisonfoundation.org.) The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: aagrawal@uci.edu
Introduction
Cells of the innate immune system such as dendritic cells (DCs)
detect and respond to pathogens through the expression of pattern
recognition receptors (PRRs). PRRs can recognize conserved
molecular components or patterns of the pathogens. Examples of
PRRs include Toll-like receptors (TLRs), RIG-I like receptors, and
Nod-like receptors [1,2]. Besides these, a new class of PRRs, the
C-type lectin receptor family has also emerged as a major sensor of
pathogens. C-type lectins recognize carbohydrate moieties on
bacteria and fungi [3–6]. Exposure of DCs to ligands of all these
PRRs results in production of cytokines that modulate the type of
T cell response and functions [1,7–8]. Upon interaction with DCs,
CD4
+ T cells can differentiate into a variety of effector and
regulatory subsets, including classical Th1 cells and Th2 cells,
follicular helper T cells, induced regulatory T cells and the more
recently defined Th17 cells [7,8]. The nature of the cytokines
produced by DCs in response to various ligands dictates the type of
Th cell responses. For example, IL-12p70 secretion by DCs
polarizes towards Th1 cells [9] while the production of IL-23
along with IL-1b from DCs leads to the generation of Th17 cells
[10,11]. Our previous studies have also shown that engagement of
different TLRs on DCs produces divergent type of adaptive
immune responses. Ligation of TLR4 and TLR5 on DCs by LPS
and Flagellin resulted in the production of IL-12p70, biasing the
Th response towards Th1. Engagement of TLR2 on DCs via
Pam3cys on the other hand generates a Th2 type of response.
However, simultaneous engagement of TLR 2/6 and Dectin-1 by
Zymosan polarized the Th cell response towards Th0 or Treg [12–
14]. DCs are thus capable of modulating the nature of T cell
responses through their cytokine secretion which in turn is
dependent on the type of receptor that is activated.
Phagocytes, such as macrophages and DCs, express several
types of C-type lectin receptors on their cell surfaces for antigen
capture. Dectin-1 is an example of C-type lectin receptor that
recognizes fungal b-glucan and is critical for its biological effects.
b-glucans are carbohydrate polymers found primarily in the cell
walls of fungi, but also in plants and some bacteria. The Dectin-1
agonist, b-glucan acts as an adjuvant as well as an immunother-
apeutic agent in the treatment of a number of diseases [3–6]. The
immune mechanisms responsible for the success of b-glucans in
immunotherapy are still unclear. Recent studies in mice suggest
that b-glucans bind to dectin-1 on phagocytes and signal via Syk
kinase independent of the TLR pathway. They prime primarily
Th17 responses [15]. Recently it was observed that DCs activated
via Dectin can convert Treg to IL17 producing cells [16]
Furthermore, they also prime cytotoxic T-lymphocyte (CTL)
responses and mount potent CTL responses [17]. Dectin-1 also
induces antibody production in rodents [18]. It is not known if a
similar mechanism exists in humans. In the present study we
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determining the response in human DCs. It is essential to
understand fully the nature of adaptive immune responses induced
in humans by these stimuli in order to harness their powerful
modulating properties to tailor immune responses against a
specific pathogen or disease.
Results
Dectin-1 agonist, Curdlan activates dendritic cells to
induce a distinct profile of cytokine secretion as
compared to Zymosan and LPS
Our previous studies had shown that stimulation of DCs by
Yeast cell wall Zymosan, a TLR 2/6 and Dectin-1 stimulus
polarized the CD4 T cell response towards T- regulatory type [14]
while E.coli LPS, a TLR4 agonist polarized it towards Th1 type
response [12]. Here we wanted to delineate further the difference
between TLR 2/6 responses from that of Dectin-1 since recent
studies [4,15] had indicated that the two responses are different.
Curdlan was chosen as a Dectin-1 agonist as Zymosan signals
through both TLR2 and Dectin-1. Curdlan is a linear b-1, 3-
glucan of ,500-mers derived from the bacterium Alcaligenes faecal.
var. myxogenes We examined the activation of DCs in response to
these stimuli. Initial experiments were performed to determine the
optimal concentrations for Zymosan and Curdlan that induced the
secretion of IL-23 or IL-12p70. Zymosan at 40 mg/ml and
Curdlan at 20 mg/ml were found to be the optimal dose for the
present study (Figure S1). The concentration of LPS [1 mg/ml]
used in these studies was chosen based on our previous studies
[12–14]. To study the effect of different agonists on DCs,
immature DCs were cultured in the presence of, Zymosan,
Curdlan and E.coli LPS. All stimuli induced maturation of DCs
within 48 h as evidenced by up-regulation of costimulatory and
maturation markers CD40, CD80, CD86, CD83 and HLADR
(Figure 1A). There was no significant difference (p.0.05) in the
level of activation induced by all three stimuli.
Next, we investigated the cytokines secreted by these stimulated
DCs. The cytokine response was remarkably different between the
various stimuli. As shown in Figure 1B, a distinct profile of IL-12
family cytokines was observed. Stimulation with Curdlan favored
IL-23 production (IL-23,900 pg/ml vs. IL-12p70,200 pg/ml)
whereas stimulation with LPS resulted in high IL-12p70
production (IL-12p70,800 pg/ml vs. IL-23,300 pg/ml). Zymo-
san was a weak inducer of both IL-23 (,40 pg/ml) and IL-12p70
(,40 pg/ml). That Curdlan-stimulated DCs biased the DC
cytokine secretion towards IL-23 was also evident when we
Figure 1. Dectin-1 agonist, Curdlan activates dendritic cells to induce a distinct profile of cytokine secretion. DCs were activated with
Curdlan, Zymosan and LPS for 48 h and upregulation of surface markers and secretion of cytokines was determined. A. Bar graph depicts the mean
fluorescence intensity [MFI] of CD40, CD80, CD86, CD83 and HLADR on DCs after activation. Figure is mean 6 S.E. of 5 such experiments. B. Bar
graphs depict the pg/ml level of IL-23 and IL-12p70 secreted by DCs in response the stimuli. C. Bar graph depicts the ratio of IL-23/IL-12p70 of the
same. D. Bar graphs depict the pg/ml level of IL-1b and IL-6 of the same. Figure is mean 6 S.E. of 10 such experiments. * Significant (,0.05), ** highly
significant (,0.005).
doi:10.1371/journal.pone.0013418.g001
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4 for Curdlan but less than 1 for both LPS and Zymosan
(Figure 1C). Besides IL-12 and IL-23, these stimuli also induced
the production of IL-1b and IL-6 from DCs. While Curdlan and
Zymosan induced IL-6 production was not significantly different
(Figure 1D), LPS induced significantly higher level (p,0.05) of IL-
6 (Figure 1D). The secretion of IL-1b was significantly different
between all three stimuli with Curdlan inducing the maximum
level (,300 pg/ml) followed by Zymosan (,150 pg/ml) and LPS
(,50 pg/ml). Taken together these data demonstrate that
stimulation of DCs through Curdlan induces distinct profile of
cytokine secretion with high IL-23, IL-1b and IL6, and relatively
low levels of IL-12p70.
Stimulation of Dectin-1 on DCs biases the Th cell
response primarily towards Th17
A large body of evidence indicates that the nature of cytokine
secretion by DCs dictates the polarization of Th cell responses
towards Th1, Th2, Treg or Th17. High IL-23 and IL-1b favor IL-
17 production from Th cells while high IL-12p70 favors IFN-c
production [7,8]. Therefore, given the distinct profile of cytokine
secretion by DCs in response to Curdlan, Zymosan and LPS, we
explored its effect on Th cell responses. DCs were cultured with
various stimuli as described in Figure 1. Two days after culture
they were washed and cultured together with purified, naı ¨ve CD4
T cells (CD4+, CD45RA+) cells for seven days to allow
differentiation of naı ¨ve T cells towards Th17 or Th1. We observed
(Figure 2) that both Curdlan and Zymosan stimulated DCs biased
the Th cell response towards Th17 and Th1 (Curdlan induced
,500 pg/ml IL-17 and 8500 pg/ml IFN- c), Zymosan induced
,350 pg/ml IL-17 and ,4000 pg/ml IFN-c). Furthermore,
Zymosan also induced significantly high levels (p,0.05) of IL-10
(,260 pg/ml) as compared to Curdlan (,50 pg/ml) (Figure 2). In
contrast, LPS stimulated DCs induced a more Th1 type of
response (,200 pg/ml IL-17 and 14000 pg/ml IFN-c, Figure 2).
Recently IL-17 secretion by Curdlan stimulated DCs was also
observed by Higashi et al [19] when they stimulated DCs with
Curdlan concentration of 1 ng/ml much lower concentration than
used by us. However, they were able to detect IL-17 only on
restimulation of T cells with anti CD3 and anti-CD28 suggesting
that the levels of IL-17 secreted were very low. Here we have used
a concentration of Curdlan which led to comparable level of DC
activation and cytokine secretion as Zymosan and LPS. In
summary, these data suggest that high IL-23 and IL-1b secretion
by Curdlan stimulated DCs induces both Th17 and Th1 cells.
Compared to Curdlan, Zymosan stimulated DCs with low IL-23
and IL-1b induced a low Th17, even lower Th1 and high IL-10
type of T cell response. LPS stimulated DCs induced primarily a
Th1 type of T cell response as before [12–14].
CD4 T cells primed with Curdlan stimulated DCs induce
IgG and IgA secretion in B cells
Next, we determined the influence of the primed CD4 T cells
with different Th cytokine responses, on the induction of various
types of Immunoglobulin’s from B cells. Naı ¨ve CD4 T cells were
primed with DCs stimulated with LPS, Zymosan and Curdlan as
above. Seven days later the T cells were collected and cultured
with allogeneic B cells. Two weeks later, supernatants were
collected and analyzed for the secretion of IgG and IgA. We
observed that Curdlan exposed DC primed CD4 T cells induced
significantly higher amount (p,0.05) of IgG and IgA secretion
compared to all other groups (Figure 3). LPS exposed DC primed
T cells also induced IgG and IgA albeit to a lower extent than
Curdlan. Zymosan exposed DC primed T cells did not induce
significant (p.0.05) IgG secretion over unstimulated DC primed
T cells. However, they did induce IgA secretion compared to
controls though the difference was not significant (p.0.05).
To investigate if the secretion of Ig by B cells required cell to cell
contact with T cells or the cytokines secreted by T cells were
sufficient for Ig induction, B cells were cultured in the presence of
supernatants obtained from stimulated DC-T cell cultures (as in
figure 2) for 14 days. Concentration of IgG and IgA in the culture
was determined as described. Zymosan, Curdlan and LPS
stimulated DC-T supernatants alone did not induce significant
levels of IgG or IgA over unstimulated DC-T cell supernatant
(Figure 3Cand D). This suggests that T and B cell contact is
essential to drive the Ig production.
Curdlan and Zymosan induce Granzyme expressing
cytotoxic CD8 T cells
In addition to influencing CD4 T cell responses, DCs also
induce the generation of cyotoxic CD8 T cell responses. To
explore this, we determined the effect of Dectin-1 stimulated DC
on CD8 T cells. DCs cultured for 48 h with various stimuli were
washed and cultured with purified CD8 T cells. Seven days later
the cells were collected and stained for intracellular granzyme A,
granzyme B and perforin. DCs stimulated with all three stimuli led
to the induction of granzyme B positive CD8 T cells (Figure 4).
However, Curdlan stimulated DCs induced the maximal number
of granzyme B positive CD8 T cells (,28%) followed closely by
Zymosan (,25%) while LPS stimulated DC induced ,15%. In
Figure 2. Stimulation of Dectin-1 on DCs biases the Th cell response primarily towards Th17. DCs activated with Curdlan, Zymosan and
LPS were cocultured with naı ¨ve CD4 T cells for seven days. Cytokine secretion was determined by ELISA. Bar graphs depict the level of IL-17, IFN-c and
IL-10 secreted by CD4 T cells. Figure is mean 6 S.E. of 10 such experiments. * Significant (,0.05), ** highly significant (,0.005).
doi:10.1371/journal.pone.0013418.g002
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significant levels (p,0.05) of perforin in CD8 T cells (Figure 4).
Granzyme A was not induced at significant levels in any of the
groups (Figure 4). These data suggest that stimulation of DCs
through Dectin-1 is highly effective in priming cytotoxic T cell
responses.
Curdlan stimulated DCs prime CD8 T cells with higher
cytolytic activity compared to Zymosan and LPS
We further determined the ability of these Granzyme expressing
CD8 T cells to lyse tumor cells. PC3, the prostate cancer cell line
(American Type Culture Collection, Manassas, VA) was used as
the source of tumor cells. PC3 specific CD8 T cells were generated
Figure 3. Dectin-1 stimulated DCs prime CD4 T cells to induce IgG and IgA in B cells. Naı ¨ve T cells primed by DCs as in figure 2 were
cultured with allogeniec, purified B cells for two weeks. IgG and IgA secretion was determined by ELISA. A. Bar graph depicts the level of IgG in the
supernatant. B. Bar graph depicts the level of IgA in the supernatant. Figure is mean 6 S.E. of 4 such experiments. * Significant (,0.05), ** highly
significant (,0.005).C. Bar graphs depict the level of IgG in the supernatant after culture of B cells with DC-T cell supernatant. D. Bar graphs depict
the level of IgA in the supernatant after culture of B cells with DC-T cell supernatant.
doi:10.1371/journal.pone.0013418.g003
Figure 4. Curdlan and Zymosan induce Granzyme expressing cytotoxic CD8 T cells. DCs activated with Curdlan, Zymosan and LPS were
cocultured with CD8 T cells for seven days. Granzyme A, granzyme B and perforin induction was determined by flow cytometry. Bar graphs depict the
percentage of CD8 T cells expressing Granzyme B, perforin and Granzyme A. Figure is mean + S.E. of 5 such experiments. * Significant (,0.05),
** highly significant (,0.005).
doi:10.1371/journal.pone.0013418.g004
Dectin Induces Th17, CD8 & IgA
PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13418as described in methods. To determine the lysis, purified CD8 T
cells (effectors) were co cultured with CFSE labeled PC3 cells
(target) at target: effector ratios 25:1, 50:1, and 100:1. Four hours
later 7-AAD was added to the cells to stain for dead cells. Controls
included CFSE-stained PC3 cells without effectors and 7AAD and
CFSE-stained PC3 cells. Analysis was performed by gating on the
target cells and measuring the 7AAD-negative vs. 7AAD-positive
cells. Cells positive for both 7-AAD and CFSE were considered
lysed. Percentage of cytotoxicity was calculated by the following
equation: (7AAD-positive CFSE-positive cells/total number of
CFSE-positive cells)6100. As seen in Figure 5, Curdlan stimulated
DCs primed CD8 T cells with higher cytolytic activity (,25% lysis
at 100:1 effector: target) ratio as compared to LPS and Zymosan
stimulated DCs (,17% lysis at 100:1 effector: target). Similar
results were observed at lower effector target ratios also. These
data clearly suggest that stimulation of DCs through Dectin-1
alone induces highly cytolytic CD8 T cells while stimulation
through a combination of TLR 2/6 and dectin-1 is not as effective.
Discussion
DCs act as a bridge between the innate and the adaptive immune
responses by sensing pathogens through PRRs and inducing
adaptive immune responses [7,8,20,21]. Though the induction
and modulation of T cell responses via engagement of TLRs is well
established [1,3] nevertheless, there is limited information regarding
the ability of non-TLR PRRs to induce and direct T cell responses.
Dectin-1 is amongst the few non-TLR PRRs that can activate DCs
and induce T cell responses [2,16,22]. Studies have shown that DCs
activated selectively via the dectin-1 acquire effector functions
similar to DCs stimulated by TLR agonists. They up-regulate
costimulatory molecules, produce TNF-a, IL-6, IL-2, IL-10, and
IL-23, and are able to prime CD4
+ T cells and instruct their
differentiation into IFN-c and IL-17 producing T-helper cells
[8,23]. Adjuvants that stimulate the dectin-1 pathway also promote
antibody responses in vivo. The dectin-1 PRR can thus couple
pathogen sensing to adaptive immune T and B cell responses.
Most of these studies have been performed in mice [15–18,24]
and little is known about Dectin-1 responses in humans. It is
essential to understand the Dectin-1 immune response in humans
in order to exploit it for human use. Our data indicates that the
responses of Dectin-1 in human DCs though essentially similar to
that found in mouse also show subtle differences. Stimulation of
DCs with Dectin-1 ligand, Curdlan led to the activation of DCs
(Figure 1A) as in mice. We also observed that DCs activated with
Curdlan were highly efficient producers of IL-23 (Figure 1B) as in
murine studies however, in contrast to mice DCs, human DCs also
induced the production of IL-12p70 though the levels induced
were lower than that of IL-23 (Figure 1B and C). In addition to IL-
12p70 and IL-23, stimulation of DCs with Curdlan also induced
high levels of IL-1b (Figure 1D). This was primarily through
Dectin-1 receptor since simultaneous engagement of TLR2 with
Dectin-1 by Zymosan led to very low levels of production of all
these cytokines. IL-1b is a central orchestrator of immunity against
various classes of pathogens [25–31], and a key trigger of
inflammatory diseases [32]. IL-23, especially in synergy with IL-
1b, plays an essential role in the induction or expansion of murine
and human Th17 cells. Indeed, culture of Curdlan stimulated DCs
with naı ¨ve CD4 T cells sustained their differentiation towards
Th17 cells as well as IFN-c producing Th cells (Figure 2). These
results are not surprising, as in humans, a substantial proportion of
IL-17 producers are found to express IFN-c [33]. Higashi et al
[19] have also observed IL-17 secretion by Curdlan activated DCs
though they did not observe IFN-c secretion. This may be a due to
differences in the concentration of Curdlan used to stimulate DCs.
The IL-17 produced in response to dectin-1 stimulation is critical
in providing protection against a range of fungal pathogens
[27,34]. Recently, Ferwarda et al [35] observed that in few
patients more susceptible to mucocutaneous fungal infections there
was an early stop codon mutation in Dectin-1 receptor which led
to poor expression of the receptor resulting in poor b-glucan
binding and subsequent impaired cytokine production.
There is very little information in the literature regarding the
type of B cell immunoglobulin response induced by CD4 T cells
expressing both IL-17 and IFN-c. It has been suggested that IL-17
producing Th cells should result in the induction of IgA since IL-
17 provides protection at mucosal surfaces. We observed that
indeed Curdlan DC primed CD4T cells induced secretion of high
levels of both IgA and IgG (Figure 3A and B) which is in keeping
with T cell cytokine profile of high IL-17 and IFN-c. Zymosan DC
primed CD4 T cells induced only low amounts of IgA and no IgG.
This may be because along with IL-17 and IFN-c the Zymosan
DC primed CD4 T cells also secreted high amounts of IL-10
(Figure 2). Activation of B cells in the presence of supernatants
containing IL-17 did not lead to Ig secretion by B cells (Figure 3C
and D) suggesting that cell to cell contact between Curdlan DC
activated T cells and B cells is required for the IgG and IgA
secretion. These observations suggest that in addition to IL-17,
Curdlan DC stimulated T cells also provide contact dependent
signals to induce IgA and IgG secretion from B cells.
Besides priming Th17 responses, Curdlan-stimulated human
DCs were extremely efficient at priming cytotoxic CD8 T cells
expressing Granzyme B and perforin as compared to both LPS
and zymosan (Figure 4). This is similar to what was observed with
murine DCs [15–17]. These perforin and granzyme B expressing
cytotoxic T lymphocytes were highly cytolytic towards tumor cells
(Figure 5) in vitro. The induction of Th17 and cytolytic CD8 T
cells by Curdlan stimulated DCs may explain its effectiveness in
cancer treatment. Beta-glucans or Curdlan are biological response
modifiers already in use as alternative cancer treatment [36–40].
b-glucans are given subcutaneously for treating and reducing the
size of skin tumors [41]. This is due to their ability to accelerate
recovery in irradiated animal specimens, even when it is given
after the radiation dose. A recent study [42] demonstrated that
repeated immunizations with two MHC class-I restricted peptides
derived from the tumor antigen survivin combined with oral co-
Figure 5. Curdlan stimulated DCs prime CD8 T cells with higher
cytolytic activity compared to Zymosan and LPS. CD8 T cells
generated as described in methods were incubated with PC3 target
cells for 4 h. Percent lysis was determined by flow cytometry. Data
represent mean 6 S.E.M. of percent specific lysis of PC3s at indicated
Effector:Target in 4 different experiments. * Significant (,0.05) as
compared unstimulated DC -CD8 T cells.
doi:10.1371/journal.pone.0013418.g005
Dectin Induces Th17, CD8 & IgA
PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13418administration of b-glucan could significantly diminish intrader-
mal tumor growth, whereas peptide vaccination alone failed to
control tumor growth. Further evidence come from the fact that
DCs from human myeloma tumor bed are potent inducers of
Th17 cells [33]. However, it is not known if these DCs can induce
cytolytic CD8 T cell responses.
In summary, we have shown that C-type lectin receptors such as
Dectin-1 are not just antigen uptake receptors but also modulators
or initiators of adaptive immune responses. These Curdlan primed
human DCs are efficient APCs for the induction of Th17 cells,
cytolytic CD8 T cells and B cell antibody responses. The capacity
of Curdlan-stimulated human DCs to induce differentiation of
these cells makes them attractive target for manipulations in clinic.
DCs are currently under intensive investigation as adjuvant for
immunotherapy against cancer and other diseases. They are also
being manipulated to expand T cells for adoptive transfer in
diseases. Targeting the induction of Th17 cells and IgA antibodies
may prove valuable in the induction of mucosal immunity and use
of Curdlan and other b-glucans as mucosal adjuvants. This is
particularly important, because though there exists a very long list
of adjuvants for systemic immunization, the number of mucosal
adjuvants is far more limited. Furthermore, Curdlan- stimulated
DCs can also serve as efficient tools to prime tumor specific
cytotoxic T cell responses. IL-17 secretion in response to Dectin-1
has also been implicated in driving autoimmunity [45]. Arthritis
could be induced in pathogen free SKG mice after treatment with
zymosan or purified b-glucans. The progression of arthritis could
be inhibited by blocking Dectin-1 [46]. Furthermore, blockage of
Dectin-1 could prevent experimental autoimmune uveoretinitis, a
Th1/Th17 disease [4]. High expression of Dectin-1 mRNA was
also observed in patients with psoriais [47]. These studies imply
that dectin-1 plays a pivotal role in the innate immune system and
is able to modulate adaptive immune responses, of which,
especially Th17 responses are implicated in immunopathology.
Dectin-1 receptor agonists are also attractive candidates as
adjuvants in vaccination against diseases such as tuberculosis
and pneumonia where IL-17 provides protective immunity [48].
These ligands may also serve as effective adjuvants in viral diseases
and conjugates of antigen-anti-dectin-1 mAb can be used to
induce CD4
+, CD8




LPS and Zymosan were obtained from Invivogen (San Diego,
CA). They were reconstituted in endotoxin free water at
concentrations of 1 mg/ml and 10 mg/ml respectively. Curdlan
was obtained from Wako Chemicals (Richmond, VA) and
suspended in PBS at 10 mg/ml.
Isolation and culture of human monocyte-derived DCs
DCs were prepared essentially as described [43]. Peripheral
blood mononuclear cells were separated over Ficoll density
gradient centrifugation. Cells were allowed to adhere to culture
plates for 2 h. Non-adherent cells were removed. The resulting
monocytes were cultured under a humidified atmosphere of 5%
CO2 at 37uC in RPMI 1640 supplemented with 10% FBS, 1 mM
glutamine, 100 U/ml penicillin, 100 mg/mlstreptomycin, 50 ng/ml
human rGM-CSF (Peprotech, NJ), and 10 ng/ml human rIL-4
(Peprotech, NJ). Half of the medium was replaced every 2 days
with fresh medium and monocyte derived DCs (DC) were collected
after 6 days. DCs were cultured with Curdlan (20 mg/ml), Zymosan
(40 mg/ml) and LPS (1 mg/ml). After 48 h, the cells were collected
for flow cytometry and supernatants were stored for cytokine
determination.
DC phenotype
This was determined by flow cytometry using a FACSCalibur




+ DCs were analyzed for the expression of CD40, CD80,
CD86, CD83 and HLADR (BD PharMingen) using Flow jo
(Treestar Inc).
Cytokine production by DCs
Cytokines, IL-1b IL-6, IL-12p70 in the supernatants were
measured by specific ELISA kits (BD Pharmingen) as per the
manufacturer’s protocol. IL-23 was measured using an ELISA kit
from eBiosciences (San Diego, CA).
DC-CD4 T cell cultures
Immature DCs were stimulated with LPS, Zymosan and
Curdlan as described above. Two days after culture, cells were
collected and washed. After washing, 2610
4 DCs were cultured
with 1610
5 purified, naı ¨ve allogeneic CD4 T cells (negative
selection kit from Stem cell Sep). Seven days later, the supernatant
was collected and the secretion of IL-17 (eBiosciences), IL-10 and
IFN-c (BD PharMingen) was assessed using ELISA.
DC-CD4 T+ B cell cultures for IgG and IgA induction
The culture of DC primed T cells with B cells was essentially as
described in the report by Schmitt et al. (44) Briefly, naı ¨ve CD4 T
cells (1610
5) generated as above were cultured with purified,
allogenic B cells at a ratio of 1:1 in 96 well plates. The purity of T
cells recovered from DC-T cell culture after 7 days was 85–91% as
determined by flow cytometry. Therefore, T cells were used
without further purification and B cells were purified by negative
selection using magnetic beads (Stem cells, Vancouver). Purity of B
cells obtained was above 92%. B cells were activated with IgM
(1 mg/ml) and CPG (0.5 mg/ml, ODN2006, Invivogen, San
Diego, CA) for 2 h prior to culture with T cells. Two weeks after
B-T culture supernatants were collected and assayed for the
presence of IgG and IgA in the supernatant by in house ELISA.
Nunc maxisorp plates were coated with 1 mg/ml of IgG or IgA
(BD Biosciences) overnight at 4uC. After overnight incubation at
4uC, the plates were blocked with PBS containing 10% Fetal
bovine serum, washed and incubated with suitable dilutions of the
supernatants. Bound Igs were detected using biotinylated detection
antibodies (1 mg/ml, BD Biosciences) and HRP-conjugated
streptavidin. After washing and addition of substrate, the optical
density in the wells was measured at 450 nm and background
values were subtracted. The average of duplicate measurements
was taken.
For culture of B cells with stimulated DC-Tcell supernatants,
purified and activated B cells 1610
5(as above) were cultured with
supernatants (1:5-supernatant: media) from LPS, Zymosan and
Curdlan stimulated and unstimulated DC-CD4T cultures (these
cultures were as described above). After two weeks secretion of IgG
and IgA was determined as described.
DC-CD8T cell cultures for granzyme induction
Immature DCs were stimulated with LPS, Zymosan and
Curdlan as described above. Two days after culture, cells were
collected and washed. After washing, 2610
4 DCs were cultured
with 1610
5 purified, allogeneic CD8 T cells (negative selection kit
from Stem cell Sep). Seven days later, cells were collected and
surface-stained for CD8 PerCP. After fixing with 4% paraformal-
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permeabilized (BD perm buffer). The cells were then stained with
antibodies to granzyme B, perforin, Granzyme A and appropriate
isotype controls (BD biosciences). Gated CD8 T cells were
analyzed for presence of granzyme and perforin.
DC-CD8T cell cultures for tumor cell lysis
DCs (1610
6) were stimulated with LPS, Zymosan, and Curdlan
as described above. Two days after culture, cells were collected
and washed. After washing, 2610
4 DCs were cultured with 1610
5
purified, allogeneic CD8 T cell along with 1610
4 irradiated PC3
(American Type Culture Collection, Manassas, VA) cells for 10
days to generate PC3 specific target cells. Subsequently, CD8 T
cells were purified from the cultures by negative selection using
magnetic beads. Purified CD8 T cells (effectors) were incubated
with CFSE-labeled PC3 cells (targets) at target: effector ratios
varying from 1:25 to 1:100 in a volume of 200 ml. Labeling with
cell tracking dye CFSE separates the targets from the effectors.
Four hours later 5 ml of 7-AAD was added to the cells to stain for
dead cells. 7-AAD only enters the membrane of compromised cells
and binds to DNA. Cells were acquired on FACS Calibur 10 min
after adding 7-AAD. 10,000 CFSE-positive cells were collected per
condition. Controls included CFSE-stained PC3 cells without
effectors and 7-AAD- and CFSE-stained PC3 cells. Analysis was
performed by gating on the target cells and measuring the 7-AAD-
negative vs. 7-AAD-positive cells. Cells positive for both 7-AAD
and CFSE were considered lysed. Percentage of cytotoxicity was
calculated by the following equation: (7-AAD-positive CFSE-
positive cells/total number of CFSE-positive cells) 6100.
Supporting Information
Figure S1 Dose response graph for Zymosan and Curdlan.
Concentrations of Zymosan and Curdlan used in the experiments
in the manuscript were chosen on the basis of IL-23 secretion.
Upper bar graphs represent the levels of IL-12 and IL-23 secreted
by DCs in response to various concentrations of Zymosan and
Curdlan. Lower graph reresents the level of IL-17 secreted by T
cells cultured with various concentrations of Zymosan and
Curdlan primed DCs.
Found at: doi:10.1371/journal.pone.0013418.s001 (0.08 MB
PDF)
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